Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunder Biomedical Tech CoROCO:4115 +0.38%52 Interest Coverage is 0.23 as of Dec. 2025, which is 90% below its 10-year median of 2.39. GuruFocus rates ROCO:4115 with a GF Score™ of 52/100 and a GF Value™ of NT$10.70 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Sunder Biomedical Tech Co ranks worse than 214592.06% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Sunder Biomedical Tech Co's
Operating Income
for the
six
months ended in Dec. 2025 was NT$1.1 Mil. Sunder Biomedical Tech Co's Interest Expense for the
six
months ended in Dec. 2025 was NT$-4.6 Mil.
Sunder Biomedical Tech Co's interest coverage for the quarter that ended in Dec. 2025 was 0.23.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Sunder Biomedical Tech Co's Interest Coverage or its related term are showing as below:
ROCO:4115's Interest Coverage is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 16.05 * Ranked among companies with meaningful Interest Coverage only.
Sunder Biomedical Tech Co (ROCO:4115) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Sunder Biomedical Tech Co Interest Coverage Related Terms
Sunder Biomedical Tech Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ROCO:4115 vs ISRG, BDX, MDLN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Sunder Biomedical Tech Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunder Biomedical Tech Co Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sunder Biomedical Tech Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Sunder Biomedical Tech Co's Interest Coverage falls into.
Sunder Biomedical Tech Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunder Biomedical Tech Co (ROCO:4115) has a Interest Coverage of 0.23 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sunder Biomedical Tech Co and its competitors. This is 90% below median its historical median of 2.39. According to the industry distribution chart, Sunder Biomedical Tech Co ranks #999999 out of 466 companies in the Medical Devices & Instruments industry.
Is Sunder Biomedical Tech Co's Interest Coverage too high?
Sunder Biomedical Tech Co's current Interest Coverage of 0.23 is 90% below median its 10-year median of 2.39. The Medical Devices & Instruments industry median Interest Coverage is 16.05. Sunder Biomedical Tech Co's value of 0.23 is 98.6% below this industry median. Based on the distribution chart, Sunder Biomedical Tech Co ranks #999999 out of 466 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sunder Biomedical Tech Co has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sunder Biomedical Tech Co's Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sunder Biomedical Tech Co ranks #999999 out of 466 companies for Interest Coverage. This places Sunder Biomedical Tech Co in the lower half of its industry. The industry median Interest Coverage is 16.05. Sunder Biomedical Tech Co's value of 0.23 is 98.6% below this benchmark. While the company's 10-year median is 2.39 vs. the industry median of 16.05, Sunder Biomedical Tech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.05, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunder Biomedical Tech Co's current Interest Coverage of 0.23 is 98.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sunder Biomedical Tech Co and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunder Biomedical Tech Co's current Interest Coverage is 0.23, which is 90% below median its own 10-year median of 2.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunder Biomedical Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Sunder Biomedical Tech Co (ROCO:4115) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$10.70, compared to a current price of NT$7.86 — trading 26.5% below its estimated fair value. The current Interest Coverage is 0.23, which is 90% below median its 10-year median of 2.39 and 98.6% below the Medical Devices & Instruments industry median of 16.05. Sunder Biomedical Tech Co's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Sunder Biomedical Tech Co (ROCO:4115), the current Interest Coverage is 0.23 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sunder Biomedical Tech Co (ROCO:4115) Overvalued in 2026?
Based on GuruFocus' analysis, Sunder Biomedical Tech Co stock appears to be undervalued.
The current stock price of NT$7.86 is trading 26.5% below its estimated GF Value™ of NT$10.70.
GuruFocus considers Sunder Biomedical Tech Co to be Modestly Undervalued.
Key valuation signals for ROCO:4115:
Interest Coverage: 0.23 (90% below median its 10-year median of 2.39)
GF Value™: NT$10.70 vs. price of NT$7.86 (26.5% below fair value)
Industry Position: 98.6% below the Medical Devices & Instruments median (#999999 of 466)
No single metric tells the full story. See the ROCO:4115 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sunder Biomedical Tech Co Ltd is engaged in providing medical devices. Its products include Protective Goggles; Meltblown Nonwoven Fabric/Mask; Suction Irrigation Set; Smoke Filter; Endo Bag; Blood Line Set for Hemodialysis and others.
52GF Score
Get the complete analysis for ROCO:4115
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4115 has been successfully added to your 
